Pee Cee Cosma Sope Board of Directors
Get the latest insights into the leadership at Pee Cee Cosma Sope. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Mayank Jain | Executive Chairman |
| Mr. Ankur Jain | Managing Director |
| Mr. Ankit Jain | Whole Time Director |
| Mr. Nirbhaya Kishore Mishra | Independent Director |
| Mrs. Aanchal Jain | Independent Director |
| Mr. Kshitiz Agarwal | Independent Director |
Pee Cee Cosma Sope Share price
PCCOSMA
495
10.20 (2.10%)Last updated on 15 Oct, 2025 | 15:05 IST
BUYSELL
Today's High
500.00
Today's Low
483.30
52 Week Low
435.05
52 Week High
929.50
The current prices are delayed, login to your account for live prices
LoginPee Cee Cosma Sope FAQs
The board at Pee Cee Cosma Sope consists of experienced professionals, including Mr. Mayank Jain , Mr. Ankur Jain , and others, overseeing the company’s strategic and corporate governance.
Directors at Pee Cee Cosma Sope are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Mayank Jain is the current chairman at Pee Cee Cosma Sope.
Executive directors at Pee Cee Cosma Sope are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Pee Cee Cosma Sope adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Pee Cee Cosma Sope, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.